Home » Amgen Wins European Approval for Blood Platelet Drug
Amgen Wins European Approval for Blood Platelet Drug
Amgen has announced that the European Commission has granted marketing authorization for Nplate for the treatment of splenectomized adult chronic immune thrombocytopenic purpura patients who are refractory to other treatments.
TradingMarkets
TradingMarkets
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May